Literature DB >> 11574235

Long-term results of multivalve surgery for infective multivalve endocarditis.

T Mihaljevic1, J G Byrne, L H Cohn, S F Aranki.   

Abstract

OBJECTIVE: The natural history of medically treated multivalvular endocarditis is associated with dismal short and long term survival. However, the impact of surgical intervention on these results is relatively unknown. The objective of this retrospective study was to report our long-term results in patients requiring multivalve surgery for multivalvular endocarditis. METHODS AND
RESULTS: Over a 24 year period beginning in 1972, multivalve surgical procedures were performed on 63 patients for infective endocarditis. Prosthetic valve endocarditis was present in 25 (40%), and acute or active endocarditis in 38 (60%). The early mortality was 16%. Out of 53 patients discharged from the hospital 87+/-4% were alive at 5 years and 64+/-9% at 10 years. There was no difference in early or late mortality between patients with prosthetic and native endocarditis (P=0.15 and P=0.77 for early and late mortality, respectively). The presence of active endocarditis did not affect operative outcome or late mortality. Twenty-one patients (88%) were in NYHA FC I, and none were in NYHA FC IV. The only prognostic factor of early and late mortality was the presence of an abscess at the time of the surgery.
CONCLUSIONS: These results indicate that multivalve infective endocarditis treated surgically is associated with acceptable early and late mortality and excellent postoperative functional status. The early surgical intervention prior to an abscess formation offers the best chance for survival of patients with multivalve endocarditis.

Entities:  

Mesh:

Year:  2001        PMID: 11574235     DOI: 10.1016/s1010-7940(01)00865-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Single and multiple valve surgery in native valve infective endocarditis.

Authors:  Tae Sik Kim; Chan-Young Na; Sam Sae Oh; Jae Hyun Kim; Gil Soo Yie; Jung Wook Han; Min Cheol Chae
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-08-06

2.  Native infective endocarditis: which determinants of outcome remain after surgical treatment?

Authors:  Sems Malte Tugtekin; Konstantin Alexiou; Manuel Wilbring; Dirk Daubner; Utz Kappert; Michael Knaut; Klaus Matschke
Journal:  Clin Res Cardiol       Date:  2006-01-16       Impact factor: 5.460

3.  Clinical and microbiologic features of multivalvular endocarditis.

Authors:  Christine Selton-Suty; Thanh Doco-Lecompte; Yvette Bernard; Xavier Duval; Lorraine Letranchant; François Delahaye; Marie Célard; François Alla; Jean-Pierre Carteaux; Bruno Hoen
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

4.  Successful treatment of polymicrobial multivalve infective endocarditis. Multivalve infective endocarditis.

Authors:  Giuseppe Allocca; Gianaugusto Slavich; Gaetano Nucifora; Massimo Slavich; Romeo Frassani; Massimo Crapis; Luigi Badano
Journal:  Int J Cardiovasc Imaging       Date:  2006-11-04       Impact factor: 2.316

Review 5.  Triple-Valve Endocarditis in a Diabetic Patient: Case Report and Literature Review.

Authors:  Anis J Kadado; Vikram Grewal; Krystel Feghali; Jaime Hernandez-Montfort
Journal:  Curr Cardiol Rev       Date:  2018

6.  Triple Valve Endocarditis With Aortic Root Abscess Presenting With Complete Heart Block and Distal Embolization.

Authors:  Mitra Patel; Zeid Nesheiwat; Neha Patel; Ronak G Soni; Mohammed Maaieh
Journal:  Cureus       Date:  2021-03-17

7.  Triple-Valve Infective Endocarditis: A Case with Unusual Features.

Authors:  Inês Oliveira; Gisela Vasconcelos; Bruno Bragança; Margarida Cruz; Glória Abreu; João Azevedo; Aurora Andrade
Journal:  Eur J Case Rep Intern Med       Date:  2022-04-27

8.  Multivalvular Endocarditis: A Rare Condition with Poor Prognosis.

Authors:  Sara Álvarez-Zaballos; Victor González-Ramallo; Eduard Quintana; Patricia Muñoz; Sofía de la Villa-Martínez; M Carmen Fariñas; Francisco Arnáiz-de Las Revillas; Arístides de Alarcón; M Ángeles Rodríguez-Esteban; José M Miró; Miguel Angel Goenaga; Josune Goikoetxea-Agirre; Elisa García-Vázquez; Lucía Boix-Palop; Manuel Martínez-Sellés
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.